Join Now

Category Archives: BioUtah News

RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]

Also posted in Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Clene Nanomedicine, Inc. Completes Enrollment in Rescue-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8

Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday announced the completion of patient enrollment in its RESCUE-ALS Phase 2 study. The multi-center study is designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in early symptomatic ALS patients. The objective of this study […]

Also posted in Life Sciences Industry News | | Leave a comment

Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]

Also posted in Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

BioUtah Statement on Launch of Altitude Lab, Largest Life Sciences Incubator in Utah

Recursion and University of Utah found incubator to propel new generation of life sciences in the region August 12, 2020 04:18 PM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah President and CEO, Kelvyn Cullimore, issued the following statement following the announcement of the opening of Altitude Lab. “This is truly a life sciences milestone in […]

Also posted in Industry News, Life Sciences Industry News | | Leave a comment

At White House Roundtable, CSL Behring CEO Paul Perreault Urges Plasma Donations to Fight COVID-19

At a July 30 White House Roundtable, plasma industry leader and CSL Behring (CSL) CEO Paul Perreault, urged people who have recovered from COVID-19 to consider donating plasma to help develop a potential treatment for people with serious complications from COVID-19. Representing the plasma industry, Perreault pointed to the unprecedented CoVIg-19 Plasma Alliance – an […]

Also posted in COVID-19 Updates, Federal News | | Leave a comment

Utah Kidney Diagnostics Company Renalytix AI Announces IPO

Exciting news comes our way this week with the announcement by BioUtah member, Renalytix AI (Renalytix), that the company is going public with a global offering of an aggregate of 11,000,000 new ordinary shares – U.S. IPO priced at $13.50 per ordinary share, and a concurrent private placement in Europe and other countries outside of […]

Also posted in Life Sciences Industry News | | Leave a comment

Utah COVID-19 Relief Programs Go Live

Last week, BioUtah News and Events, reported that a number of new grant programs established by the Utah State Legislature would be soon open for applications through the Governor’s Office of Economic Development (GOED).  This week, detailed information on three of the programs, ComRent, Safe In Utah, and Shop In Utah have come online. In […]

Also posted in COVID-19 Updates, State News | | Leave a comment

Recap of Stock Market Update with Monica DiCenso of JP Morgan

After leaving quite an impression to the attendees of the 2020 Entrepreneur and Investor Summit, we brought Monica DiCenso, managing director and head of Global Investment Opportunities Group at J.P. Morgan, back for a mid-year update on the stock market. In the webinar, Ms. Dicenso provided important insight into the rebound of the economy since […]

Also posted in Industry News, Life Sciences Events | | Leave a comment

BioUtah Joins ‘InUtah’ Campaign

The recently launched statewide ‘In Utah’ campaign encourages protecting public health and economic reactivation as we continue to navigate COVID-19. BIoUtah has joined the ‘InUtah’ campaign as a partner to help get the word out and promote our own life sciences community. The campaign’s purpose is to educate Utahns on the opportunities and benefits of […]

Also posted in State News | | Leave a comment

New Utah COVID-19 Economic Relief Programs Take Shape

New and improved grant programs, aimed at providing economic support to Utah businesses impacted by COVID-19, are being finalized under the Governor’s Office of Economic Development (GOED). These programs, a result of legislation, HB 5010, which passed the state legislature during a June special session, include a revamped Commercial Rental Assistance Program (ComRent), making it […]

Also posted in Funding, State News | | Leave a comment

BioFire Respiratory Panel with COVID Target Scores CE Mark

BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19 viruses, and four bacteria that cause the most frequent respiratory tract infections, has received CE marking.  “It’s exciting to see the advances that BioFire is making in COVID-19 and infectious disease diagnostics,” said Kelvyn Cullimore, president and […]

Also posted in Federal News, Industry News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

PhotoPharmics Stay-At-Home Trial for People with Parkinson’s

This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center to conduct an at home, telemedicine, phase 3 trial for the company’s Celeste® – a non-invasive, specialized light therapy device for Parkinson’s. The trial follows an FDA Breakthrough Device Designation for the device in […]

Also posted in Federal News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment